文献速递肾癌与肾肿瘤

慢性肾脏病与肾癌手术:新视角

Chronic Kidney Disease and Kidney Cancer Surgery: New Perspectives.
PubMed 文献 · J Urol · 2019-05-07

本文通过检索2002至2018年MEDLINE文献,综述慢性肾脏病与肾癌手术的关系,并评估部分与根治性肾切除术的生存获益差异。文章指出慢性肾脏病评估需综合考虑病因、肾小球滤过率水平和白蛋白尿程度,术后肾小球滤过率低于45 ml/min/1.73 m²是更具判别力的预后阈值,回顾性研究中部分肾切除术的生存获益可能受选择偏倚影响。

要点

  • 慢性肾脏病评估应综合病因、肾小球滤过率水平及白蛋白尿程度,不能仅依据肾小球滤过率低于60 ml/min/1.73 m²。
  • 术后肾小球滤过率低于45 ml/min/1.73 m²是更具判别力的预后阈值。
  • 回顾性研究中部分肾切除术的生存获益可能受选择偏倚影响,唯一随机试验未显示生存获益。

核心结论

  • 肾癌患者术前肾小球滤过率低于60 ml/min/1.73 m²或术后低于45 ml/min/1.73 m²时,慢性肾脏病的预后风险增加。
  • 非手术原因的慢性肾脏病和白蛋白尿程度等因素可显著改变肾癌术后慢性肾脏病的后果。
  • 泌尿外科医生需全面了解慢性肾脏病,以评估部分与根治性肾切除术的风险与获益。

研究设计与样本

  • 综合文献检索:检索MEDLINE® 2002年至2018年相关文章,关键词包括根治性肾切除术、部分肾切除术、肾小球滤过率、肾功能和慢性肾脏病,并评估相关综述和学会指南。

主要发现

  • 泌尿外科文献常仅将慢性肾脏病定义为肾小球滤过率低于60 ml/min/1.73 m²,忽略了病因和白蛋白尿的意义。
  • 术前肾小球滤过率低于60 ml/min/1.73 m²对肾肿瘤手术术前评估有意义,但近期研究提示术后肾小球滤过率低于45 ml/min/1.73 m²是更具判别力的预后阈值。
  • 回顾性研究中部分肾切除术较根治性肾切除术报告的生存获益可能受选择偏倚影响。
  • 唯一一项部分与根治性肾切除术随机试验中,部分肾切除术队列未显示生存获益,这与考虑慢性肾脏病病因和术后肾小球滤过率后各研究组患者因慢性肾脏病死亡风险相对较低的数据一致。

关键数值与推荐

  • 慢性肾脏病评估包括病因、肾小球滤过率水平和白蛋白尿程度。
  • 术前肾小球滤过率低于60 ml/min/1.73 m²或术后低于45 ml/min/1.73 m²与慢性肾脏病预后风险增加相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We sought to provide a contemporary understanding of chronic kidney disease and its relevance to kidney cancer surgery. Another purpose was to resolve points of discrepancy regarding the survival benefits of partial vs radical nephrectomy by critically evaluating the results of prospective and retrospective studies in the urological literature. MATERIALS AND METHODS: We performed a comprehensive literature search for relevant articles listed in MEDLINE® from 2002 to 2018 using the key words radical nephrectomy, partial nephrectomy, glomerular filtration rate, kidney function and chronic kidney disease. We also assessed select review articles and society guidelines about chronic kidney disease pertinent to urology and nephrology. RESULTS: Complete evaluation of the potential consequences of chronic kidney disease involves assessment of the cause, the glomerular filtration rate level and the degree of albuminuria. Chronic kidney disease is commonly defined in the urological literature solely as a glomerular filtration rate less than 60 ml/minute/1.73 m2. This ignores the significance of the cause of chronic kidney disease, and the presence and degree of albuminuria. Although this glomerular filtration rate is relevant for preoperative assessment of patients who undergo surgery of kidney tumors, recent studies suggest that a glomerular filtration rate less than 45 ml/minute/1.73 m2 represents a more discerning postoperative prognostic threshold. Reported survival benefits of partial over radical nephrectomy in retrospective studies were likely influenced by selection bias. The lack of survival benefit in the partial nephrectomy cohort in the only randomized trial of partial vs radical nephrectomy was consistent with data demonstrating that patients in each study arm were at relatively low risk for mortality due to chronic kidney disease when accounting for the chronic kidney disease etiology and the postoperative glomerular filtration rate. CONCLUSIONS: The prognostic risk of chronic kidney disease in patients with kidney cancer is increased when the preoperative glomerular filtration rate is less than 60 ml/minute/1.73 m2 or the postoperative rate is less than 45 ml/minute/1.73 m2. Additional factors, including nonsurgical causes of chronic kidney disease and the degree of albuminuria, can also dramatically alter the consequences of chronic kidney disease after kidney cancer surgery. Urologists must have a comprehensive knowledge of chronic kidney disease to assess the risks and benefits of partial vs radical nephrectomy when managing tumors with increased complexity and/or oncologic aggressiveness.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Huang WC, Donin NM, Levey AS, et al. Chronic Kidney Disease and Kidney Cancer Surgery: New Perspectives. J Urol. 2019. PMID: 31063051. doi:10.1097/JU.0000000000000326

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。